Login / Signup

Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker Analysis.

Stefano IndraccoloGian Luca De SalvoMartina VerzaMario CacceseGiovanni EspositoIlaria PigaPaola Del BiancoMarco PizziMarina Paola GardimanMarica EoliRoberta RudàAlba Ariela BrandesToni IbrahimSimona RizzatoIvan LolliVittorina ZagonelGiuseppe Lombardi
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
We found that AMPK pathway activation is associated with clinical benefit from treatment with regorafenib in relapsed GBM.
Keyphrases
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • diffuse large b cell lymphoma
  • hodgkin lymphoma
  • metastatic colorectal cancer
  • skeletal muscle
  • phase iii
  • phase ii
  • open label